Michael Grissinger insider trades

Open-market stock purchases and sales by Michael Grissinger, Director at Lipocine Inc, from SEC Form 4 filings since Nov 5, 2018.

Recent trades

DateStockTradeValue
Aug 3, 2026LPCN Lipocine IncBought (not open market)$4.2K
Jun 21, 2026ACET Adicet Bio, IncBought (not open market)—
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—

Companies traded

  • LPCN Lipocine Inc: other filings, last Aug 3, 2026
  • ACET Adicet Bio, Inc: other filings, last Jun 21, 2026
  • APRE Aprea Therapeutics, Inc: other filings, last Jun 16, 2026
  • AKTX Akari Therapeutics plc: other filings, last Jun 28, 2024
  • TORC resTORbio, Inc: other filings, last Jun 3, 2020

Get free alerts when Michael Grissinger files a new trade →